Last $46.12 USD
Change Today +0.70 / 1.54%
Volume 104.6K
ALKS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 10:22 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert A. Breyer

Director, Member of Nominating & Corporate Governance Committee and Member of Audit & Risk Committee, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 2 different industries.

See Board Relationships
70$492,769

Background*

Mr. Robert A. Breyer, also known as Bob served as the President of Alkermes Inc. from July 1994 to December 2001 and its Chief Operating Officer from July 1994 to February 2001. Mr. Breyer was a Part-Time Employee of Alkermes. From August 1991 to December 1993, he served as the President and General Manager of Eli Lilly Italy, a subsidiary of Eli Lilly and Company. From September 1987 to August 1991, he served as Senior Vice President of Marketing and Sales at IVAC Corporation, ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 772 8000
Fax: --

Board Members Memberships*

2005-N/A
Former Director
2011-Present
Director, Member of Nominating & Corporate Governance Committee and Member of Audit & Risk Committee

Education*

BS 1966
North Dakota State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$67,361
Total Calculated Compensation$492,769
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALKS:US $46.12 USD +0.70

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$916.2K
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Alessandro E. Della Chà LL.MChief Executive Officer and Director
Cosmo Pharmaceuticals S.p.A.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.